UCTV Seminars

description:

A big obstacle to developing stem cell therapies is being able to visualize the cells inside the body. This will be critical to confirm that the stem cells are targeted to the right place and are providing therapeutic benefit. Current imaging technology are not adequate for tracking stem cells in vivo. Magnetic Particle Imaging, MPI, is a new methodology that has promise to be 200 times more sensitive than magnetic resonance imaging (MRI). Steven Conolly, whose UC Berkeley lab is pioneering MPI, speaks about his research.

more on this subject:

Entering the RNA World with Sidney Altman

Cancer Nanotechnology - Opportunities and Challenges - View from the NCI Alliance for Nanotechnology in Cancer

Encoding Contingency

see all from Cell and Developmental Biology >

host links:

California Institute for Regenerative Medicine (CIRM)